V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160016345 | 160019163 | 1.62 | 116.9 | Palliative (P) | 2020-04-12 | 2020-04-28 | Ifosfamide | 02 | N | EW EUROEWING 2012 ARM B IE | 100784492 |
| 160016348 | 160019164 | null | 79 | Palliative (P) | 2018-03-28 | 2018-03-28 | EW EuroEwing 2012 Arm B VDC/IE | 02 | N | NOT MATCHED | 100954658 |
| 160016361 | 160019166 | 1.59 | 68.7 | 03 | 2021-12-01 | 2021-12-01 | Dinutuximab Beta | 02 | N | PEMETREXED | 101091128 |
| 160016366 | 160019167 | 0 | 83 | Neo-adjuvant (N) | 2019-02-11 | 2019-02-17 | Ifosfamide | 02 | N | EW EUROEWING 2012 ARM B VC | 101311932 |
| 160016388 | 160019169 | 1.73 | 84.2 | Palliative (P) | 2017-12-11 | 2018-05-31 | Raltitrexed | 02 | N | RITUXIMAB | 101042391 |
| 160016409 | 160019170 | 1.58 | 94.25 | Curative (C) | 2019-05-08 | 2019-06-01 | Olaratumab | 02 | N | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | 101579720 |
| 160016428 | 160019171 | 1.73 | 91.5 | null | 2020-02-10 | 2020-02-14 | Cisplatin + Etoposide (3 day) | N | null | NB HRNBL-1 ISOTRETINOIN | 101731054 |
| 160016429 | 160019172 | 1.73 | 77 | Adjuvant (A) | 2017-07-06 | 2017-07-07 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVADO | 100736808 |
| 160016440 | 160019173 | 1.56 | 15.6 | Palliative (P) | 2016-12-31 | 2016-12-31 | CONFIRM TRIAL | 02 | null | ACALABRUTINIB | 100907107 |
| 160016444 | 160019174 | null | 69.5 | Curative (C) | 2020-06-14 | 2020-06-24 | Doxorubicin + Ifosfamide | 02 | N | CONFIRM TRIAL | 100920605 |
| 160016447 | 160019175 | 1.61 | 72 | Palliative (P) | 2019-04-27 | 2019-05-05 | Carboplatin + Vinorelbine IV | 01 | N | MELPHALAN | 101003237 |
| 160016462 | 160019176 | 1.68 | 79.4 | Curative (C) | 2016-11-05 | 2017-05-15 | IPM | 02 | N | IVA | 101660087 |
| 160016467 | 160019177 | null | null | Palliative (P) | 2018-11-17 | 2018-12-04 | PEMBROLIZUMAB | 2 | N | LIPOSOMAL DAUNORUBICIN | 100434212 |
| 160016479 | 160019179 | 1.6 | 45 | Adjuvant (A) | null | 2019-08-10 | STS Rhabdo VIT0910 Vinc Irinotecan | 02 | N | STS NON-RHABDO EPSSG 2005 IFOS | 100294636 |
| 160016488 | 160019180 | 1.87 | 91.5 | null | 2018-04-26 | 2018-07-20 | VINCRISTINE | 02 | null | EURO-EWING | 100949605 |
| 160016489 | 160019181 | 1.67 | 17.5 | Palliative (P) | 2017-05-15 | 2017-09-03 | FLUOROURACIL + IRINOTECAN | 02 | null | EW EUROEWING 2012 ARM B IE | 100100749 |
| 160016492 | 160019182 | 1.86 | 64 | Curative (C) | null | null | EW EuroEwing 99 : VActI | 02 | N | CARBOPLATIN + VINORELBINE | 101692118 |
| 160016503 | 160019183 | 1.78 | 68.4 | Curative (C) | 2017-06-22 | 2017-07-16 | IVA | 02 | N | PROMISE-MESO TRIAL | 101759217 |
| 160016526 | 160019184 | 1.68 | 94 | Curative (C) | null | null | BUSULFAN + MELPHALAN | 02 | N | GEMCITABINE | 101319145 |
| 160016528 | 160019185 | 1.81 | 79 | null | 2020-12-14 | 2021-02-08 | Cyclophosphamide + Vincristine | 02 | null | ETOP 13-18 BEAT-MESO TRIAL | 101194974 |
| 160016540 | 160019186 | null | null | Palliative (P) | 2021-10-16 | 2021-10-22 | LANREOTIDE | 02 | N | PEMBROLIZUMAB | 101003034 |
| 160016547 | 160019187 | 1.8 | 16.5 | Palliative (P) | 2018-10-10 | 2019-03-26 | GEMCITABINE | 02 | N | STS RHABDO RMS 2005 VIN CYCLO | 100387025 |
| 160016557 | 160019188 | 1.93 | 54.3 | Curative (C) | 2016-07-20 | 2020-12-28 | CONFIRM TRIAL | 02 | null | IVA | 100069644 |
| 160016583 | 160019189 | 0 | 91 | Curative (C) | 2020-09-06 | 2020-11-15 | Irinotecan + Temozolomide | 02 | N | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 101370304 |
| 160016587 | 160019191 | 1.65 | 7.9 | null | 2021-08-11 | 2022-02-18 | GEMCITABINE | 02 | null | GEMCITABINE | 101439690 |
| 160016589 | 160019192 | 0 | 12.3 | null | 2022-03-09 | 2022-04-11 | STS Rhabdo RMS 2005 Vin Cyclo | null | null | EW EUROEWING 2012 ARM B VDC/IE | 100705812 |
| 160016596 | 160019193 | 1.66 | 78.5 | null | 2020-02-02 | 2020-02-22 | EW EuroEwing 2012 Arm B IE | 02 | null | GEMCITABINE | 101238130 |
| 160016601 | 160019194 | null | 19.9 | Adjuvant (A) | 2017-02-19 | 2017-09-09 | null | 2 | N | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 101288706 |
| 160016613 | 160019195 | 1.88 | 114.6 | Curative (C) | 2017-04-11 | 2017-08-07 | Doxorubicin + Ifosfamide | 02 | N | NB HRNBL-1 ISOTRETINOIN | 101487963 |
| 160016634 | 160019196 | 1.36 | 54.9 | Curative (C) | 2018-08-24 | 2018-09-18 | Ifosfamide | 02 | null | DOXORUBICIN + IFOSFAMIDE | 101340491 |
| 160016636 | 160019197 | 0 | 18.5 | Curative (C) | 2020-12-06 | 2021-01-13 | EW EuroEwing 99 : VActC | 02 | N | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | 100921383 |
| 160016641 | 160019199 | 1.66 | 73.4 | null | null | 2017-06-09 | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 02 | null | STS RHABDO RMS 2005 VIN CYCLO | 100119618 |
| 160016655 | 160019200 | 1.71 | 14 | null | 2019-12-28 | 2019-12-30 | FLUOROURACIL + IRINOTECAN | 02 | null | STS RHABDOMYOSARCOMA RMS 2005 IVADO | 100203446 |
| 160016666 | 160019201 | 1.77 | 55.6 | null | 2019-12-30 | 2020-02-08 | Olaparib | 02 | null | ENZALUTAMIDE | 101163761 |
| 160016669 | 160019202 | 0 | 33.8 | Neo-adjuvant (N) | 2020-07-06 | 2020-08-31 | Gemcitabine day 1&8 | 02 | N | EW EUROEWING 99 : VACTI | 101742044 |
| 160016686 | 160019203 | 1.68 | 83.5 | null | 2017-07-21 | 2017-07-23 | NB HRNBL-1 COJEC Ind COURSE B | 02 | null | EW EUROEWING 2012 ARM B VC | 100022000 |
| 160016698 | 160019204 | 1.19 | 25.8 | Palliative (P) | 2019-12-23 | 2020-01-13 | Ifosfamide | null | Y | DOCETAXEL + TRASTUZUMAB | 100699335 |
| 160016706 | 160019205 | null | 17.9 | Adjuvant (A) | 2020-10-09 | 2020-10-16 | GC Int Guide Excranial GermCell JEB | 01 | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 100928396 |
| 160016710 | 160019206 | 1.57 | 58.7 | Neo-adjuvant (N) | 2017-01-21 | 2017-02-10 | Abiraterone | 02 | N | EW REL REECUR IRINOTECAN/TEMOZOLOMIDE | 100954690 |
| 160016711 | 160019207 | 1.74 | 63.5 | Palliative (P) | 2017-11-13 | 2018-03-19 | Cyclophosphamide oral | 02 | null | EW EUROEWING 2012 ARM A VAI | 100851842 |
| 160016712 | 160019208 | 1.7 | 62.3 | Curative (C) | 2020-05-23 | 2021-04-03 | null | 01 | N | CYCLOPHOSPHAMIDE + TOPOTECAN | 100683768 |
| 160016721 | 160019209 | 1.77 | 90.3 | Neo-adjuvant (N) | 2019-01-11 | 2019-06-23 | PEMBROLIZUMAB | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVADO | 100121389 |
| 160016728 | 160019210 | 1.71 | 65 | null | 2019-12-31 | 2020-01-04 | null | 02 | null | ETOPOSIDE | 101189672 |
| 160016732 | 160019211 | 1.63 | 3.9 | null | null | 2019-06-26 | EW EuroEwing 2012 Arm A VAC | 02 | null | OLAPARIB | 100892266 |
| 160016741 | 160019212 | 0 | 66.95 | null | null | 2018-01-27 | null | 02 | null | GEMCITABINE | 101717234 |
| 160016745 | 160019213 | 1.63 | 11.2 | null | 2020-05-26 | 2020-08-15 | NB HRNBL-1 Isotretinoin | 01 | null | IFOSFAMIDE | 101560703 |
| 160016747 | 160019214 | 1.1 | 69.5 | null | 2017-03-31 | 2017-04-15 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | EURO-EWING | 100820783 |
| 160016749 | 160019215 | null | null | null | 2019-03-07 | 2019-06-14 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | null | OLARATUMAB | 100080250 |
| 160016752 | 160019216 | 1.64 | 64.3 | Curative (C) | 2018-04-01 | 2018-04-15 | Niraparib | 01 | null | NOT MATCHED | 101614131 |
| 160016779 | 160019217 | 1.54 | 34 | Curative (C) | 2020-08-03 | 2021-01-06 | Docetaxel 75mg/m2 (21 day) | 01 | N | GEMCITABINE | 100909788 |